GLP-1 Drugs and Cancer Research Reach Major Turning Point
[Core Summary] The Washington Post reports major new findings in the research relationship between GLP-1 drugs and cancer, triggering heightened interest from the scientific community. These drugs, originally developed for diabetes and weight management, may play a significant role in cancer prevention and treatment. [Perspective] The expansion of GLP-1 drugs from diabetes and weight management into cancer research represents an important trend in modern medicine: drug repurposing. The scientific basis for this phenomenon lies in the established link between obesity and multiple cancer types. By improving metabolic function and reducing inflammation levels, GLP-1 drugs may indirectly influence cancer development. ...